CLTR at The American Society of Hematology
41st Annual Meeting and Exposition
December 3-7, 1999
Ernest N. Morial Convention Center New Orleans, Louisiana
CLTR will participate in two symposium presentations at ASH.
hematology.org
Immunotherapy in Non-Hodgkin's Lymphoma: New Treatment Advances
This program is sponsored by the University of Michigan Medical School and supported through an unrestricted educational grant from Coulter Pharmaceutical and SmithKline Beecham Oncology.
3:00pm - 6:30pm, New Orleans Hilton Riverside Hotel
This symposium will discuss both current and evolving biologic modalities used in the treatment of Non-Hodgkin's Lymphoma (NHL). Topics will include the role of biologics in NHL, the potential use of Vaccines as treatment for NHL, Radioimmunotherapy (RIT), I-131 Anti-B1 therapy for NHL, unconjugated antibody and the combined use of RIT and hematopoietic stem cell transplant in the treatment of indolent NHL. Who should attend? This program is designed for oncologists, hematologists and other healthcare professionals as an overview of both current and future biologically focused therapies for the treatment of NHL.
For more information, contact Kathleen Clapp, Coulter Pharmaceutical (650) 553-1189; fax (650) 553-2026;
kathleen_clapp@coulterpharm.com.
CORPORATE FRIDAY SYMPOSIA - FRIDAY, DECEMBER 4, 199
Emerging Role of Radioimmunotherapy for Management of Non-Hodgkin's Lymphoma 8:00 am - 12:30 pm, Loews Miami Beach Supported by an educational grant from Coulter Pharmaceutical
This symposium will review current and evolving data on the pathophysiology and treatment strategies for Non-Hodgkin's lymphoma, focusing on low-grade B-cell malignancies. The role of radioimmunotherapy in the management of Non-Hodgkin's lymphoma, including development and progress of anti-B1 antibody therapy, will be described. Pharmacology, mechanisms of action, and clinical experience of anti-B1 antibody therapy in the settings of relapsed/refractory B-cell lymphomas, autologous stem cell transplantation, and initial therapy will be highlighted.
For more information, contact program registration at Scientific Therapeutics Information, Inc., (973) 376-5655;
fax (973) 376-0611. Refer to program 1284. |
